When it comes to protection against ultraviolet radiation–induced erythema and sunburn, sunscreen with sun protection factor (SPF) 100+ is significantly better than that with SPF 50+ in actual use at the beach, a recent study has shown.
The use of fish oil and its components may yield favourable effects on psoriasis and its comorbidities, namely obesity, cardiovascular disease and metabolic disease, when combined with conventional treatments, as reported in a recent study.
Patients with pemphigus or pemphigoid are at increased risk of developing multiple cutaneous, extracutaneous and systemic autoimmune disorders, which then correlate with a substantial cost burden, suggests a recent study.
Interleukin (IL)-1α inhibition with bermekimab appears to be safe and effective in the treatment of moderate-to-severe hidradenitis suppurativa, inducing clinical response without raising substantial safety concerns, according to the results of a phase II trial.
Treatment with low-dose methotrexate (LD-MTX) leads to small-to-moderate increases in risks for skin cancer and gastrointestinal, infectious, pulmonary and haematologic adverse events (AEs), as well as a decrease in renal AEs, a study has shown.
A recent study reports a mean growth rate of proximal aorta of about 0.1 mm/year in hypertensive patients with known aortic dilatation. In addition, those with increased rather than normal aortic z score have slower dilatation over time.
Knee osteoarthritis (OA), whether symptomatic or radiographic, contributes to an increased risk of all-cause mortality, with the risk increase from symptomatic knee OA partially attributed to its effect on disability and quality of life (QoL).
It takes just less than 4 days for COVID-19 to spread from one person to another and cause symptoms, and more than 10 percent of the cases are infected by a person who has caught the virus but yet to show symptoms, recent studies suggest.